Besnoitia besnoiti infection alters both endogenous cholesterol de novo synthesis and exogenous LDL uptake in host endothelial cells.
Animals
Biomarkers
Cattle
Cattle Diseases
/ metabolism
Cholesterol
/ metabolism
Dietary Supplements
Endothelial Cells
/ drug effects
Fluorescent Antibody Technique
Gas Chromatography-Mass Spectrometry
Host-Parasite Interactions
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/ pharmacology
Lipid Metabolism
/ drug effects
Lipidomics
/ methods
Lipoproteins, LDL
/ metabolism
Sarcocystidae
/ physiology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
30 04 2019
30 04 2019
Historique:
received:
08
11
2018
accepted:
12
04
2019
entrez:
2
5
2019
pubmed:
2
5
2019
medline:
21
10
2020
Statut:
epublish
Résumé
Besnoitia besnoiti, an apicomplexan parasite of cattle being considered as emergent in Europe, replicates fast in host endothelial cells during acute infection and is in considerable need for energy, lipids and other building blocks for offspring formation. Apicomplexa are generally considered as defective in cholesterol synthesis and have to scavenge cholesterol from their host cells for successful replication. Therefore, we here analysed the influence of B. besnoiti on host cellular endogenous cholesterol synthesis and on sterol uptake from exogenous sources. GC-MS-based profiling of cholesterol-related sterols revealed enhanced cholesterol synthesis rates in B. besnoiti-infected cells. Accordingly, lovastatin and zaragozic acid treatments diminished tachyzoite production. Moreover, increased lipid droplet contents and enhanced cholesterol esterification was detected and inhibition of the latter significantly blocked parasite proliferation. Furthermore, artificial increase of host cellular lipid droplet disposability boosted parasite proliferation. Interestingly, lectin-like oxidized low density lipoprotein receptor 1 expression was upregulated in infected endothelial hostcells, whilst low density lipoproteins (LDL) receptor was not affected by parasite infection. However, exogenous supplementations with non-modified and acetylated LDL both boosted B. besnoiti proliferation. Overall, current data show that B. besnoiti simultaneously exploits both, endogenous cholesterol biosynthesis and cholesterol uptake from exogenous sources, during asexual replication.
Identifiants
pubmed: 31040348
doi: 10.1038/s41598-019-43153-2
pii: 10.1038/s41598-019-43153-2
pmc: PMC6491585
doi:
Substances chimiques
Biomarkers
0
Hydroxymethylglutaryl-CoA Reductase Inhibitors
0
Lipoproteins, LDL
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6650Références
Mol Med. 2014 Jan 17;20:1-9
pubmed: 24306512
Biochim Biophys Acta. 2012 Feb;1818(2):330-6
pubmed: 21745458
Exp Parasitol. 1989 May;68(4):482-5
pubmed: 2656283
J Steroid Biochem Mol Biol. 2017 May;169:4-9
pubmed: 26733205
Cell Microbiol. 2013 Jul;15(7):1182-97
pubmed: 23311949
J AOAC Int. 2015 May-Jun;98(3):674-676
pubmed: 25942061
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14551-6
pubmed: 16199524
Tissue Cell. 2003 Feb;35(1):59-67
pubmed: 12589730
Future Oncol. 2010 Apr;6(4):551-62
pubmed: 20373869
J Pharmacol Exp Ther. 2017 Jul;362(1):186-199
pubmed: 28476928
Cell Microbiol. 2006 Jan;8(1):1-9
pubmed: 16367861
J Lipid Res. 2010 Nov;51(11):3364-9
pubmed: 20688754
Int J Parasitol. 2006 Apr;36(4):423-31
pubmed: 16500654
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Apr 15;957:116-22
pubmed: 24674990
J Parasitol. 2009 Apr;95(2):474-6
pubmed: 18803440
Parasit Vectors. 2014 Jan 13;7:20
pubmed: 24410743
Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1541-7
pubmed: 9763524
Nat Rev Cardiol. 2011 May;8(5):253-65
pubmed: 21321561
Methods Enzymol. 2008;438:109-29
pubmed: 18413244
Vet Rec. 2005 Aug 27;157(9):262-4
pubmed: 16127139
Mol Biochem Parasitol. 2004 Feb;133(2):145-52
pubmed: 14698427
Parasitol Res. 2014 Nov;113(11):4165-76
pubmed: 25199551
Circ Res. 1998 Aug 10;83(3):322-7
pubmed: 9710125
Anal Biochem. 1978 Oct 1;90(1):420-6
pubmed: 727482
Cell Microbiol. 2011 Apr;13(4):569-86
pubmed: 21105984
J Pediatr Oncol Nurs. 2002 Nov-Dec;19(6):229-33
pubmed: 12444575
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):933-9
pubmed: 16467108
J Lipid Res. 2002 Jul;43(7):1078-85
pubmed: 12091492
Int J Antimicrob Agents. 2009 Feb;33(2):185-6
pubmed: 18996682
Vet Parasitol. 2006 Dec 20;142(3-4):214-22
pubmed: 16930845
Lipids Health Dis. 2005 May 09;4:10
pubmed: 15882457
Parasit Vectors. 2014 Jan 23;7:47
pubmed: 24457118
Vet Rec. 2016 Jun 11;178(24):608
pubmed: 27122500
Eukaryot Cell. 2015 May;14(5):454-73
pubmed: 25750213
Biochem J. 2012 Feb 15;442(1):171-80
pubmed: 22077443
Parasitol Res. 2014 Nov;113(11):4189-97
pubmed: 25193048
Nature. 1997 Mar 6;386(6620):73-7
pubmed: 9052782
Mol Aspects Med. 2016 Jun;49:23-30
pubmed: 27086126
Parasitol Res. 2016 May;115(5):2023-34
pubmed: 26852124
Mol Biochem Parasitol. 2004 Jun;135(2):197-209
pubmed: 15110461
J Cell Biol. 2000 Apr 3;149(1):167-80
pubmed: 10747095
Int J Parasitol. 1988 Apr;18(3):291-6
pubmed: 3135277
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3450-4
pubmed: 10716717
Parasitology. 2014 Sep;141(11):1406-17
pubmed: 24694568
Vet Res. 2015 Sep 23;46:100
pubmed: 26395984
J Biol Chem. 2001 Sep 14;276(37):34434-40
pubmed: 11457847
Vet Parasitol. 2013 Dec 6;198(3-4):265-73
pubmed: 24120579
J Submicrosc Cytol Pathol. 1998 Apr;30(2):299-307
pubmed: 9648294
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Vet Parasitol. 2006 Nov 5;141(3-4):226-33
pubmed: 16822614
Vet Parasitol. 2012 Mar 23;184(2-4):108-15
pubmed: 21978744
J Infect Dis. 2011 Sep 15;204(6):951-61
pubmed: 21849292
Vet Parasitol. 1991 Aug;39(3-4):207-13
pubmed: 1957481
Biochim Biophys Acta. 2007 Jun;1768(6):1311-24
pubmed: 17493580
J Biol Chem. 1995 Apr 21;270(16):9083-96
pubmed: 7721822
Prog Lipid Res. 2008 Nov;47(6):391-404
pubmed: 18502209
Vet Parasitol. 2009 Aug 26;163(4):315-22
pubmed: 19477592
Cell Microbiol. 2005 Jun;7(6):849-67
pubmed: 15888087
Antimicrob Agents Chemother. 1994 May;38(5):1144-8
pubmed: 8067753
Mol Microbiol. 2004 Oct;54(1):109-22
pubmed: 15458409
Int J Parasitol. 2005 May;35(6):597-615
pubmed: 15862574
Trends Parasitol. 2013 Aug;29(8):407-15
pubmed: 23830145
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Biophys J. 2011 Feb 16;100(4):948-56
pubmed: 21320439
J Vet Med Sci. 2011 May;73(5):633-9
pubmed: 21187676
Vet Res. 2010 Sep-Oct;41(5):70
pubmed: 20615380
Cell. 2006 Apr 21;125(2):261-74
pubmed: 16630815
Trends Endocrinol Metab. 2012 Mar;23(3):99-106
pubmed: 22244444
Int J Parasitol. 2007 Oct;37(12):1329-41
pubmed: 17537443
PLoS One. 2014 Mar 11;9(3):e91415
pubmed: 24618849
Vet Parasitol. 2007 May 31;146(3-4):352-6
pubmed: 17418951
Mol Microbiol. 2013 Mar;87(5):951-67
pubmed: 23374239
J Antimicrob Chemother. 2006 Jul;58(1):59-65
pubmed: 16702175
Vet Rec. 2010 May 8;166(19):599
pubmed: 20453244